share_log

IO Biotech Ended 2022 With ~$142.7M In Cash And Cash, Anticipates This Will Be Sufficient To Fund Operations Into Mid-2024

Benzinga Real-time News ·  Jan 9, 2023 07:22
IO Biotech Ended 2022 With ~$142.7M In Cash And Cash, Anticipates This Will Be Sufficient To Fund Operations Into Mid-2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment